Idamycin Pfs
NDC Package 0013-2201-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Idamycin Pfs is idarubicin is used to treat a certain type of cancer (leukemia). Marketed by Pharmacia And Upjohn Company, this product is identified by NDC 0013-2201 and is authorized under FDA application NDA050734.

Identification & Billing

NDC Package Code
0013-2201-01
Package Description
10 mL in 1 VIAL, SINGLE-USE
Product Code
0013-2201
11-Digit Billing Format
00013220101

Clinical Specifications

Proprietary Name
Idamycin Pfs
Dosage Form
-
Usage Information
Idarubicin is used to treat a certain type of cancer (leukemia). It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Pharmacia And Upjohn Company
FDA Application #
NDA050734
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-17-1997
End Marketing Date
01-07-2015
Listing Expiration
01-07-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0013-2201-01 identifies a specific commercial package of 10 ml in 1 vial, single-use of Idamycin Pfs, labeled by Pharmacia And Upjohn Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmacia And Upjohn Company on February 17, 1997. The current certification is valid through January 07, 2015.

What are the primary indications for this medication?

Idarubicin is used to treat a certain type of cancer (leukemia). It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.

How is this Pharmacia And Upjohn Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00013220101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0013-2201-01
11-Digit CMS (5-4-2)
00013-2201-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.